A Favorable Metabolic and Antiatherogenic Profile in Carriers of CYP21A2 Gene Mutations Supports the Theory of a Survival Advantage in This Population

Publisher: Karger

E-ISSN: 1663-2826|72|6|337-343

ISSN: 1663-2818

Source: Hormone Research in Paediatrics, Vol.72, Iss.6, 2009-10, pp. : 337-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract